bluecross blueshield glp 1 coverage Why we are changing of GLP-1 drugs for weight loss Why Blue Cross Blue Shield

These medications have been extensively studied and have demonstrated benefits in diabetes management, weight reduction, cardiovascular risk reduction, and improvement in overall metabolic health for appropriately selected patients

N = 161,798 after matching GLP-1RA vs diet/exercise consultation Median follow-up: 2 years Key result: Any obesity-associated cancer HR 0.59, 95% CI 0.53-0.67 Site-specific signals: Multiple myeloma HR 0.37 Pancreatic cancer HR 0.40 Endometrial cancer HR 0.42 Colorectal cancer HR 0.49 But remember: This is observational

Semaglutide and personalized hormone dosing can help restore balance and support sustainable weight loss

PlexusDx provides compounded semaglutide from licensed pharmacies with transparent information about common and serious side effects

We divided the subjects into obesity and non-obesity group and compared their expression levels between them